title: Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
abstract: OBJECTIVE
  The use of genetically engineered mouse (GEM) models for preclinical testing of anticancer therapies is hampered by variable tumor latency, incomplete penetrance, and complicated breeding schemes. Here, we describe and validate a transplantation strategy that circumvents some of these difficulties.
  
  
  METHODS
  Tumor fragments from tumor-bearing MMTV-PyMT or cell suspensions from MMTV-PyMT, -Her2/neu, -wnt1, -wnt1/p53(+/-), BRCA1/p53(+/-), and C3(1)T-Ag mice were transplanted into the mammary fat pad or s.c. into naïve syngeneic or immunosuppressed mice. Tumor development was monitored and tissues were processed for histopathology and gene expression profiling. Metastasis was scored 60 days after the removal of transplanted tumors.
  
  
  RESULTS
  PyMT tumor fragments and cell suspensions from anterior glands grew faster than posterior tumors in serial passages regardless of the site of implantation. Microarray analysis revealed genetic differences between these tumors. The transplantation was reproducible using anterior tumors from multiple GEM, and tumor growth rate correlated with the number of transplanted cells. Similar morphologic appearances were observed in original and transplanted tumors. Metastasis developed in >90% of mice transplanted with PyMT, 40% with BRCA1/p53(+/-) and wnt1/p53(+/-), and 15% with Her2/neu tumors. Expansion of PyMT and wnt1 tumors by serial transplantation for two passages did not lead to significant changes in gene expression. PyMT-transplanted tumors and anterior tumors of transgenic mice showed similar sensitivities to cyclophosphamide and paclitaxel.
  
  
  CONCLUSIONS
  Transplantation of GEM tumors can provide a large cohort of mice bearing mammary tumors at the same stage of tumor development and with defined frequency of metastasis in a well-characterized molecular and genetic background.
authors.affiliation: Center for Cancer Research, National Cancer Institute, Frederick, Maryland. varticol@mail.nih.gov
authors.forename: Lyuba
authors.initials: L
authors.lastname: Varticovski
authors.forename: Melinda G
authors.initials: MG
authors.lastname: Hollingshead
authors.forename: Ana I
authors.initials: AI
authors.lastname: Robles
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Wu
authors.forename: James
authors.initials: J
authors.lastname: Cherry
authors.forename: David J
authors.initials: DJ
authors.lastname: Munroe
authors.forename: Luanne
authors.initials: L
authors.lastname: Lukes
authors.forename: Miriam R
authors.initials: MR
authors.lastname: Anver
authors.forename: John P
authors.initials: JP
authors.lastname: Carter
authors.forename: Suzanne D
authors.initials: SD
authors.lastname: Borgel
authors.forename: Howard
authors.initials: H
authors.lastname: Stotler
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Bonomi
authors.forename: Nomelí P
authors.initials: NP
authors.lastname: Nunez
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Hursting
authors.forename: Wenhui
authors.initials: W
authors.lastname: Qiao
authors.forename: Chuxia X
authors.initials: CX
authors.lastname: Deng
authors.forename: Jeff E
authors.initials: JE
authors.lastname: Green
authors.forename: Kent W
authors.initials: KW
authors.lastname: Hunter
authors.forename: Glenn
authors.initials: G
authors.lastname: Merlino
authors.forename: Patricia S
authors.initials: PS
authors.lastname: Steeg
authors.forename: Lalage M
authors.initials: LM
authors.lastname: Wakefield
authors.forename: J Carl
authors.initials: JC
authors.lastname: Barrett
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression; D020869:Gene Expression Profiling; D005818:Genetic Engineering; D017403:In Situ Hybridization; D008325:Mammary Neoplasms, Experimental / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation / Q000379:methods*; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction